The cells in most tumors are found to carry multiple mutations; however, based upon mutation rates determined by fluctuation tests, the frequency of such multiple mutations should be so low that tumors are never detected within human populations. Fluctuation tests, which determine the cell-division-dependent mutation rate per cell generation in growing cells, may not be appropriate for estimating mutation rates in nondividing or very slowly dividing cells. Recent studies of time-dependent, "adaptive" mutations in nondividing populations of microorganisms suggest that similar measurements may be more appropriate to understanding the mutation origins of tumors. Here I use the ebgR and ebgA genes of Escherichia coli to measure adaptive mutation rates where multiple mutations are required for rapid growth. Mutations in either ebgA or ebgR allow very slow growth on lactulose (4-0-fJ-D-galactosyl-D-fructose), with doubling times of 3.2 and 17.3 days, respectively. However, when both mutations are present, cells can grow rapidly with doubling times of 2.7 hr. I show that during prolonged (28-day) selection for growth on lactulose, the number of lactulose-utilizing mutants that accumulate is 40,000 times greater than can be accounted for on the basis of mutation rates measured by fluctuation tests, but is entirely consistent with the time-dependent adaptive mutation rates measured under the same conditions of prolonged selection.
The origins of many cancers and tumors involve progressive chromosomal aberrations and multiple mutations in different genes (1) (2) (3) (4) (5) . About 25% of human colon cancers contain more than nine mutations (6) , and Loeb (7) argues that most tumors contain at least four mutations, while Stein (8) argues for five mutations. Whether four, five, or more mutations are required, Loeb and Stein agree that if the mutations occur independently at about 1.4 x 10-10 per base pair per cell division (7) , the frequency of human tumors should be so low that tumors are never detected (7) (8) (9) .
The evidence that multiple mutations play a causal role in the development of human tumors is so strong that the failure of measured mutation rates to account for the observed number of mutations indicates a fundamental failure in understanding the origins of mutations in humans. Either the measurements of spontaneous mutation rates have been off by several orders of magnitude, which seems very unlikely, or the wrong thing has been measured; i.e., the measured rates are irrelevant to the phenomenon of tumorigenesis.
Luria and Delbruck (10) showed that, in Escherichia coli, mutations could occur in the absence of the environmental challenge that selected for the mutant phenotype. This meant that those mutations had not been caused by selection, but that selection had acted only to reveal the existence of preexisting mutations. As additional studies in both bacteria and higher organisms confirmed that view, a stronger interpretation of the
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evidence led to the dogma that selection and mutation were completely separate processes in which mutations occurred completely randomly with respect to their eventual effect on the organism, and selection acted only to alter the frequencies of those random mutations in subsequent generations. The universality of that dogma has recently been strongly challenged by a series of studies which have shown that during periods of prolonged, intense selection, microbial cells can specifically generate mutations that are useful to them at the time. The findings of these recent studies do not conflict with those of Luria and Delbruck and others because all those earlier studies employed lethal selections that could detect only preexisting mutations. All of the recent studies have employed nonlethal selection, which can detect both preexisting mutations and mutations that may be caused by the selection itself.
Adaptive mutations (sometimes called directed, selectioninduced, or Cairnsian) are spontaneous mutations that occur during periods of prolonged stress as specific responses to environmental challenges and that occur more often when they are selectively advantageous than when they are selectively neutral. The key feature that distinguishes "adaptive" from "random" mutations is their specificity; i.e., they appear to occur only in the genes that are under intense selection. Adaptive mutations have been shown to occur in at least eight loci in E. coli (11) (12) (13) (14) (15) , at one locus in Clostridium thermocellum (16) , and at three loci in Saccharomyces cerevisiae (17, 18) . They have been shown to arise by base substitutions (11, 14, 17, 19) , by both positive and negative frameshifts (18) (19) (20) , and by precise excision of mobile genetic elements (IS150 and Tn3) (12, 15) . A report purporting to show that excision of IS150 is not adaptive (21) has now been refuted (22) . Adaptive mutations are thus a general phenomenon in terms of the loci at which they can occur, in terms of the nature of the mutations, and in terms of their occurrence in both prokaryotes and eukaryotes.
In a typical experiment a strain of E. coli that requires a nutrient, such as tryptophan, is grown on solid medium that contains a limiting supply of that nutrient. When the nutrient is exhausted, there is a sparse population present on each plate. Mutants, typically revertants that no longer require the nutrient, continue to grow and form small colonies, or papillae, on the sparse bacterial lawn. The number of mutant colonies that appear within a day after the nutrient is exhausted is consistent with the number that would be expected based on the rate at which that allele spontaneously mutates as estimated by the Luria-Delbruck fluctuation test (10) . During continued incubation new mutant colonies appear continuously over periods ranging from a few days up to several weeks (for reviews see refs. 23 and 24); i.e., the measured random mutation rate does not correctly predict the ultimate number of mutants that appear in the population.
Adaptive mutations appear to be specific to the gene that is under selection; i.e., during selection for Trp+ revertants in a Abbreviation: IPTG, isopropyl ,B-D-thiogalactopyranoside. trpB cysB double mutant, no Cys+ revertants were detected, nor were Trp+ revertants detected when the same strain was subjected to selection for Cys+ revertants (14) . Strauss (9) has discussed the potential relationship between adaptive mutations in bacteria and the origin of mutations in tumor cells. He has pointed out that spontaneous rates are measured by fluctuation tests in growing cell populations and are probably irrelevant to the development of most tumors. Instead, he argues, developing tumors are similar to E. coli cells kept under nondividing conditions during prolonged selection. Under those conditions the relevant measure is the timedependent adaptive mutation rate, and mutation continues in the absence of cell proliferation.
The purpose of this paper is to examine further the parallels between adaptive mutations in microorganisms and the origins of mutations that ultimately lead to the development of tumors in higher organisms. In particular, the purpose is to ask whether adaptive mutations in E. coli may serve as a useful model to explain the multiple mutational origins of tumors. (26) . CMSD-met medium (25) is a defined, complete medium that includes each of the 20 common amino acids, except methionine, at 20 ,ug/ml. L agar (27) was used as a rich medium. Growth Rates. The number of viable cells per plate (N,) was estimated by suspending plugs from lactulose selection plates and plating appropriate dilutions onto rich medium. The growth rate, k, was estimated from a least-squares fit of ln(N,) vs. t, based upon the relationship N, = Noekt, where t is expressed in days and k is expressed in days-1.
Fluctuation Tests. Random mutation rates were determined by fluctuation tests. A set of independent 10-ml cultures were grown in glycerol mineral salts medium containing IPTG. Samples (10 ,l) were removed from 10 cultures, diluted, and spread onto rich medium to determine the number of viable cells per culture, after which the entirety of each culture was concentrated by centrifugation and spread onto a plate containing lactulose minimal medium plus IPTG.
The average number of mutations that occurred during the Approximately 105 cells were spread onto lactulose selection medium, which was MS medium containing a limiting supply of glycerol (0.01%), an excess of lactulose (0.1%), IPTG, and (when X342LD scavenger cells were used) methionine (100 ,ug/ml). The plates were incubated at 30°C in a humidified chamber to prevent dehydration of the medium. Glycerol was exhausted when the population density, which varied from experiment to experiment, was 5 x 108 to 2.5 x 109 cells per plate, after which lactulose-utilizing mutants appeared as papillae (small colonies on the thin lawn) over the next few weeks.
Measurement of Adaptive Mutation Rates. The number of lactulose-utilizing papillae was counted each day. Because reconstruction tests have shown that papillae are visible within 48 hr, each papilla was scored as a mutation that occurred 2 days previously. The number of viable cells per plate was estimated by suspending plugs from lactulose selection plates and plating appropriate dilutions onto rich medium or, when X342LD scavenger cells were present, onto CMSD-met medium upon which the metB-X342LD cells cannot grow. The adaptive mutation rate was calculated as the average number of mutations per plate divided by the number ofviable cells per plate and is expressed as the number of mutations per cell per day.
RESULTS
System for Detecting Multiple Mutations. The ebg operon of E. coli, located on the opposite side of the chromosome from the lac operon, encodes a second ,B-galactosidase that is an alternative to the better known lacZ ,B-galactosidase system. Mutations in the ebg operon can allow lacZ deletion strains of E. coli to utilize lactose and other ,3-galactoside sugars as sole carbon and energy sources (26, (29) (30) (31) . The ebgAC genes encode the a and 83 subunits, respectively, of Ebg enzyme, while the ebgR gene encodes a repressor that controls expression of the ebgAC genes (26, 32) . The wild-type Ebg enzyme (ebgA0 gene product) hydrolyzes lactulose (galactosyl-3-1,4-fructose) very inefficiently, and the Ebg repressor (ebgR+ gene product) is virtually insensitive to lactulose as an inducer (26, 33) . As a result, AlacZ strains are unable to utilize lactulose as a carbon and energy source.
A mutation from G to either C or T at base pair 4223 of the ebg operon (ebgA +'I allele) results.in the replacement of Trp977 by Cys in the a subunit of Ebg enzyme (32) and increases the activity toward lactulose by 30-fold at physiological substrate concentrations (34) . Mutations to ebgR-result in constitutive synthesis of Ebg enzyme as about 5% of the soluble protein of the cell (26) . Together these two mutations permit growth on. lactulose at the rate of 0.26 hr-1 (a doubling time of 2.7 hr).
Neither of these mutations alone permitted detectable growth on lactulose (growth rate < 0.03 hr-1, doubling time >35 hr) (refs. 26 and 32; unpublished results). Selection for growth on lactulose by the AlacZ strain DS4680A provides a means to study adaptive multiple mutations.
Growth Rates of the Single-Mutant Intermediates. Although neither single mutant (ebgR-ebgA0 or ebgR+ ebgA+II) permitted detectable growth on lactulose as measured by growth in liquid medium over a period of about 24 hr, it was important to determine the growth rates of those intermediates during prolonged incubation on plates-the conditions under which the multiple-adaptive-mutation experiment would be carried out. Fig. 1 shows the growth of each single mutant on lactulose plates. The growth rate of strain lB1 (ebgR-ebgA0) was 0.04 ± 0.022 day-1 (growth rate ± 95% confidence limits), which is a doubling time of 17.3 days; the growth rate of strain SA1 (ebgR+ ebgA4+1) was 0.222 ± 0.053 day-1, which is a doubling time of 3.2 days. Note that the points in this particular experiment could be interpreted as strain 5A1 lagging for 5 days, then beginning to grow at the rate of 0.286 day-1, and strain lB1 lagging for 8 days, then beginning to grow at 0.116 day-'. This interpretation would affect only the expected number of double mutants in Fig. 4 , where it slightly improves the agreement between observed and expected values.
Mutation Rates. Random mutation rates. The random mutation rates in growing cultures were determined by fluctua- tion tests (10) as described in Materials and I mutation rate (,u) from ebgR+ to ebgR-was ml independent cultures of strain SA1 and was 7.6 x division. The mutation rate from ebgA0 to ebgA sured in 100 independent cultures of strain lBi z 10-10 per cell division.
Adaptive mutation rates. Mutation rates durin selection on lactulose medium were determinec A io- strains. Fig. 2A shows the mutation rates from ebgR+ to ebgRin three experiments in which the number of initial SA1 cells was varied, and also shows the "combined" rates that were obtained by averaging the common results of the three experiments. The mutation rate to ebgR-increased from 2 x 10-9 per cell per day to 10-5 per cell per day over a period of 10 days.
In contrast, the mutation rate to ebgA+"I remained fairly constant over a period of 4 weeks (the change in mutation rate was 7.3 ± 19.7 x 10-11 per cell per day per day, and the probability that the slope was not different from zero was 0.23), with the average mutation rate over that period being 2.5 ± 0.45 x 10-9 per cell per day (Fig. 2B ).
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The mutations that occurred during prolonged selection on lactulose medium cannot be accounted for on the basis of the random mutation rates that were measured in growing cells. lactulose. The  Fig. 3 shows the observed accumulation of lactulose-utilizing tulose minimal mutants compared with that which would be expected from random, replication-dependent mutations. Wethods. The
The mutations to ebgR-during prolonged selection for easured in 61 lactulose utilization were nonrandom also in the sense that : Fig. 2 . The observed accumulation of ebgR-mutants is based upon the data shown in Fig. 2A, and by fluctuation tests, and from the growth rates of each of the single-mutant intermediates (Fig. 4) . A total of 28 lactuloseutilizing double mutants were obtained in this experiment, which is 40,000 times more than the 0.0007 that would have been expected, based solely upon random mutations, by day 28. In contrast, when the adaptive mutation rates each day were used, the expected number of mutants was very close to the observed number each day (Fig. 4) . It is important to note that the adaptive mutation rates from ebgR+ to ebgR-and from ebgA+ to ebgA+I1 can, for experimental reasons, be measured only in strains that already have the other mutations. While it is possible that these mutation rates might be different in a nonmutant background, the close agreement between the observed kinetics with which double mutants appear and the predicted kinetics based on the adaptive mutation rates suggests that the mutation rates do not depend upon the presence of the other mutation. These results suggest that although random, replication-dependent mutations are insufficient to produce multiple mutations during prolonged selection, adaptive mutations may do so quite effectively.
DISCUSSION
The firstlactulse-utlizinmutatapparWhether we are considering spontaneous (36), x-ray-induced
The first lactulose-utilizing mutant appeared on day (37) , or oncogene-induced (38) there would be powerful selection for both its retention and its improvement. The finding that both bacteria and yeast can produce adaptive mutations is consistent with the notion that the ability evolved early and is widely distributed. The machinery that produces adaptive mutations would be very useful in single-cell organisms but might be deleterious in multicell organisms where the requirement for organizing cells into tissues means that programmed growth constraints must be applied to most cells. In multicellular organisms the activation of that adaptive-mutagenesis machinery, which would be advantageous to the individual cell in that it would allow that cell to divide rapidly, would be very disadvantageous to the organism, where the rapidly growing population would be described as a tumor. Given the similarities between adaptive mutations in E. coli and tumorigenesis, it is not unreasonable to expect that further studies of adaptive mutations may shed additional light upon the processes by which cancers arise. For instance, Loeb's (7) suggestion that the initial step in tumorigenesis may be the occurrence of mutator mutations (8) did not appear to be supported by the observations that tumor cells do not seem to have increased mutation rates (39, 40) . Recently, however, Loeb (43) has made a convincing case for mutator phenotypes in some cancers on the basis of instability of microsatellite DNA in some tumor cell lines (44) and on the finding that lesions in human genes that are homologous to the mismatch repair gene mutS (45) and mutL (46) of E. coli account for the majority of hereditary nonpolyposis colorectal cancers. On the other hand, it is clear that not all tumor lines show a mutator phenotype. The failure to find elevated mutation rates in earlier studies (39, 40) and in 11 of the 14 colorectal carcinoma cell lines studied by Bhattacharyya et aL (44) may itself be misleading because mutator mutations that increased the mutation rates in only nondividing cells would not have been detected in those studies. A recent study (25) has shown that lesions in the excision repair system of E. coli (uvrA, uvrB, and uvrC genes) increase the adaptive mutation rate by about 100-fold but do not increase the random mutation rate. Mutations with similar effects (not necessarily lesions in excision repair) might well be a common feature of tumor cells. It is to be hoped that current efforts to identify genes involved in adaptive mutagenesis will produce information that will lead to the identification of genes involved in tumorigenesis in humans.
